Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Italy / NCT07312968
Active, not recruiting Observational

AI4Triage - Development of an Artificial Intelligence Based Methods for the Analysis of Triage Data.

NCT07312968 · tracked via the Priya Life Science Italy tracker
Sponsor
University of Catanzaro
Phase
Observational
Started
2025-11-01
Last updated
2026-01-06

Condition(s) studied

Triage

Investigational drug(s) / intervention(s)

Observation

Observation: there is no intervetiuons

Study summary

Artificial intelligence, and in particular Graph Neural Networks (GNNs), have shown enormous potential in the analysis of complex clinical data. Thanks to their ability to model relationships between variables, GNNs represent a significant evolution compared to traditional models, enabling better interpretation of medical information and supporting data-driven decision-making in complex contexts such as emergency medicine.

The application of GNNs to clinical triage and to the prediction of length of stay can improve clinical efficiency by optimizing resource allocation and patient management. This observational study aims to evaluate the accuracy of predictions with respect to real clinical data, contributing to the development of advanced predictive tools to support healthcare decision-making processes.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria: * all Exclusion Criteria: * Patients labelled with red codes and serious injuries.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
University of Catanzaro Catanzaro Italy

More University of Catanzaro trials in Italy

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07312968 on ClinicalTrials.gov ↗ ← All trials in Italy